Stoke Therapeutics STOK
NASDAQ STOK
$25.92 -0.09 (-0.35%)
As of: Oct 2, 2026 · 12:34 PM EDT

Stoke Therapeutics (STOK) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Stoke Therapeutics' Depreciation & Amortization (CF) came in at $458,000 for Q2 2026, up 2.7% from $446,000 a year earlier and up 4.3% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Stoke Therapeutics reported Depreciation & Amortization (CF) of $1.77 million, down 11.8% year-over-year; for FY2025, it came in at $1.8 million, down 18.2% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $2.2 million in FY2024 (-12.0%), $2.5 million in FY2023 (+61.7%), $1.55 million in FY2022 (+54.6%) and $1 million in FY2021 (+11.1%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q1 2025.
  • Year-over-year, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with an average decline of 13.7%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q1 2023 (growth of 141.7%), and the weakest in Q4 2025 (a decline of 20.8%).
  • Business Quant data shows STOK's Depreciation & Amortization (CF) at $439,000 (Q1 2026), $435,000 (Q4 2025) and $442,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 458,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 458,000.00
Mar 31, 2026 439,000.00
Dec 31, 2025 435,000.00
Sep 30, 2025 442,000.00
Jun 30, 2025 446,000.00
Mar 31, 2025 477,000.00
Dec 31, 2024 549,000.00
Sep 30, 2024 540,000.00
Jun 30, 2024 548,000.00
Mar 31, 2024 563,000.00
Dec 31, 2023 655,000.00
Sep 30, 2023 637,000.00
Jun 30, 2023 611,000.00
Mar 31, 2023 597,000.00
Dec 31, 2022 609,000.00
Sep 30, 2022 388,000.00
Jun 30, 2022 302,000.00
Mar 31, 2022 247,000.00
Dec 31, 2021 261,000.00
Sep 30, 2021 254,000.00
API Access

Stoke Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=STOK&period=max&api_key=YOUR_API_KEY